Conjunctivitis associated with COVID-19
Pro Research Analysisby 
Searched over 200M research papers
Prevalence and Incidence of COVID-19-Associated Conjunctivitis
Studies show that conjunctivitis is a recognized but relatively uncommon symptom in patients with COVID-19. Reported prevalence rates vary widely, from as low as 0.8% to as high as 31.6%, depending on the study design and patient population 2510. Most large studies and meta-analyses estimate the incidence to be between 1% and 11% among hospitalized or confirmed COVID-19 cases 1234+1 MORE. Conjunctivitis is the most common ocular manifestation reported in both adults and children with COVID-19 45.
Clinical Features and Presentation of COVID-19-Related Conjunctivitis
COVID-19-associated conjunctivitis typically presents as acute, self-limited redness (hyperemia) of the eye, sometimes accompanied by tearing, stinging, or photophobia 1347. Most cases are mild, do not affect visual acuity, and resolve without treatment or complications 134. Other ocular symptoms such as pain or discharge are rare . In some cases, conjunctivitis can be the first or only symptom of COVID-19, especially in the early stages of infection 67. Both unilateral and bilateral presentations have been observed, with unilateral cases being more common .
Risk Factors and Demographics
Younger age and a history of smoking have been identified as independent risk factors for developing conjunctivitis in COVID-19 patients . The condition appears to be less common in the elderly . Frequency of hand-eye contact is also considered a risk factor, highlighting the importance of protective measures, especially for healthcare workers .
Association with COVID-19 Severity
There is evidence that conjunctivitis is more frequent in patients with severe COVID-19, and its presence may be a warning sign of poor outcomes 210. However, some studies have found no clear relationship between the severity of COVID-19 and the occurrence of conjunctivitis 19. The variability in findings may be due to differences in study populations and definitions of severity.
Transmission and Diagnostic Considerations
The ocular surface may serve as an entry point and reservoir for SARS-CoV-2, but the risk of transmission through tears or conjunctival secretions remains uncertain 479. Bilateral conjunctival sampling within nine days of symptom onset increases the likelihood of detecting the virus . However, the conjunctiva is likely not a preferred portal of entry for the virus, possibly due to lower expression of viral entry receptors and protective factors in tears .
Management and Prognosis
COVID-19-related conjunctivitis generally has a self-limiting course and resolves without specific treatment 134. Supportive care is usually sufficient, and there are no reported long-term complications affecting vision 134. Physicians should consider COVID-19 in patients presenting with acute conjunctivitis, even in the absence of respiratory symptoms, to prevent missed diagnoses and further spread 6710.
Conclusion
Conjunctivitis is an established but uncommon manifestation of COVID-19, most often presenting as mild, self-limited eye redness. It can occur at any stage of infection and may be the only symptom in some cases. While more frequent in severe cases, the overall risk remains low. Awareness of this association is important for early detection and infection control, especially in healthcare settings.
Sources and full results
Most relevant research papers on this topic